NCT00600691View on ClinicalTrials.gov

The Use of Finasteride to Reduce Hematuria and Hematospermia Following TRUS Prostate Biopsy

PHASE2TerminatedINTERVENTIONAL

Enrollment

29

Participants

Timeline

Start Date

March 31, 2008

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions

HematuriaHematospermia

Interventions

DRUG

Finasteride

one tablet (5mg) of finasteride

Trial Locations (2)

Unknown

Royal Jubilee Hospital, Victoria

Victoria General Hospital, Victoria

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Health Canada

OTHER_GOV

collaborator

Merck Frosst Canada Ltd.

INDUSTRY

lead

University of British Columbia

OTHER